Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Gallardo

Showing results (151-160 of 168) with videos related to

Pageof 17
Sort By:
Msphere|February 18, 2021
Correction for Hutson et al., "Pharmacokinetics and Efficacy of a Potential Smallpox Therapeutic, Brincidofovir, in a Lethal Monkeypox Virus Animal Model"Christina L Hutson, Ashley V Kondas, Mathew R Mauldin, et al.
Msphere|February 4, 2021
Pharmacokinetics and Efficacy of a Potential Smallpox Therapeutic, Brincidofovir, in a Lethal Monkeypox Virus Animal ModelChristina L Hutson, Ashley V Kondas, Mathew R Mauldin, et al.
Cancer Immunity|January 8, 2010
Correlation of clinical and immunological data in a metastatic melanoma patient with heterogeneous tumor responses to ipilimumab therapyJianda Yuan, David B Page, Geoffrey Y Ku, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2010
Immunologic response to xenogeneic gp100 DNA in melanoma patients: comparison of particle-mediated epidermal delivery with intramuscular injectionBrian A Ginsberg, Humilidad F Gallardo, Teresa S Rasalan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 18, 2008
Phase I/II study of GM-CSF DNA as an adjuvant for a multipeptide cancer vaccine in patients with advanced melanomaMiguel-Angel Perales, Jianda Yuan, Sarah Powel, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 22, 2011
Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumabJianda Yuan, Matthew Adamow, Brian A Ginsberg, et al.
Journal of Wildlife Diseases|May 26, 2016
ENDEMIC ORTHOPOXVIRUS CIRCULATING IN PROCYONIDS IN MEXICONadia F Gallardo-Romero, Nidia Aréchiga-Ceballos, Ginny L Emerson, et al.
Nature Biotechnology|March 26, 2003
Serial in vivo imaging of the targeted migration of human HSV-TK-transduced antigen-specific lymphocytesGuenther Koehne, Mikhail Doubrovin, Ekaterina Doubrovina, et al.
Archivos De Cardiologia De Mexico|March 4, 2021
[Effectiveness and safety of the surgical closure of permeable arteriosus conduct by the general pediatric surgeon: clinical trial]Antonio F Gallardo-Meza, José M González-Sánchez, Francisco Vidrio-Patrón, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 17, 2008
CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefitJianda Yuan, Sacha Gnjatic, Hao Li, et al.
Pageof 17

Showing results (151-160 of 168) with videos related to

Sort By:
Pageof 17
Msphere|February 18, 2021
Correction for Hutson et al., "Pharmacokinetics and Efficacy of a Potential Smallpox Therapeutic, Brincidofovir, in a Lethal Monkeypox Virus Animal Model"Christina L Hutson, Ashley V Kondas, Mathew R Mauldin, et al.
Msphere|February 4, 2021
Pharmacokinetics and Efficacy of a Potential Smallpox Therapeutic, Brincidofovir, in a Lethal Monkeypox Virus Animal ModelChristina L Hutson, Ashley V Kondas, Mathew R Mauldin, et al.
Cancer Immunity|January 8, 2010
Correlation of clinical and immunological data in a metastatic melanoma patient with heterogeneous tumor responses to ipilimumab therapyJianda Yuan, David B Page, Geoffrey Y Ku, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2010
Immunologic response to xenogeneic gp100 DNA in melanoma patients: comparison of particle-mediated epidermal delivery with intramuscular injectionBrian A Ginsberg, Humilidad F Gallardo, Teresa S Rasalan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 18, 2008
Phase I/II study of GM-CSF DNA as an adjuvant for a multipeptide cancer vaccine in patients with advanced melanomaMiguel-Angel Perales, Jianda Yuan, Sarah Powel, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 22, 2011
Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumabJianda Yuan, Matthew Adamow, Brian A Ginsberg, et al.
Journal of Wildlife Diseases|May 26, 2016
ENDEMIC ORTHOPOXVIRUS CIRCULATING IN PROCYONIDS IN MEXICONadia F Gallardo-Romero, Nidia Aréchiga-Ceballos, Ginny L Emerson, et al.
Nature Biotechnology|March 26, 2003
Serial in vivo imaging of the targeted migration of human HSV-TK-transduced antigen-specific lymphocytesGuenther Koehne, Mikhail Doubrovin, Ekaterina Doubrovina, et al.
Archivos De Cardiologia De Mexico|March 4, 2021
[Effectiveness and safety of the surgical closure of permeable arteriosus conduct by the general pediatric surgeon: clinical trial]Antonio F Gallardo-Meza, José M González-Sánchez, Francisco Vidrio-Patrón, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 17, 2008
CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefitJianda Yuan, Sacha Gnjatic, Hao Li, et al.
Pageof 17